Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sleep Initiation and Maintenance Disorders 1 Pain 1 Multiple Myeloma 1 Fatigue 1 Depression 1 Caregiver Burden 1 Cancer Diagnosis 1 Anxiety Disorders 1

Interventions

Dexamethasone 238 Lenalidomide 145 daratumumab 123 Bortezomib 101 pomalidomide 86 Calcium Dobesilate 76 carfilzomib 74 Cyclophosphamide 70 Specimen Handling 42 isatuximab 40 Biopsy 40 fludarabine 36 belantamab mafodotin 36 Magnetic Resonance Spectroscopy 35 talquetamab 29 dexamethasone acetate 27 dexamethasone 21-phosphate 27 Melphalan 27 auricularum 26 iberdomide 25 ixazomib 22 fludarabine phosphate 22 selinexor 21 elotuzumab 21 Whole-Body Irradiation 14 X-Rays 13 tocilizumab 12 venetoclax 11 Mycophenolic Acid 10 trametinib 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × Caregivers × 1 year × Clear all

NCT07276230 2025-12-29

ENTRAIDANT

Assistance Publique - Hôpitaux de Paris

Phase NA Not yet recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡